80 related articles for article (PubMed ID: 8999328)
21. [LIPID study [Long-term Intervention with Pravastatin in Ischaemic Disease study]].
Homma Y
Nihon Rinsho; 2001 Mar; 59 Suppl 3():416-21. PubMed ID: 11347106
[No Abstract] [Full Text] [Related]
22. Long-term follow-up of the West of Scotland Coronary Prevention Study.
Tsubokura M; Kami M
N Engl J Med; 2008 Jan; 358(2):193-4; author reply 194-5. PubMed ID: 18193526
[No Abstract] [Full Text] [Related]
23. Cholesterol-lowering agent in men without CHD.
Millard P; Johnson KH
J Fam Pract; 1996 Mar; 42(3):223-4. PubMed ID: 8636668
[No Abstract] [Full Text] [Related]
24. Japan: are statins still good for everybody?
Sirtori CR; Calabresi L
Lancet; 2006 Sep; 368(9542):1135-6. PubMed ID: 17011926
[No Abstract] [Full Text] [Related]
25. In patients with heart disease, is the benefit of lipid-lowering therapy with statins similar in older patients to that in younger patients?
Adelman A
J Fam Pract; 2001 Nov; 50(11):924. PubMed ID: 11711002
[No Abstract] [Full Text] [Related]
26. A need to redefine the consensus on the use of statins in coronary heart disease prevention.
Fruchart JC
Eur Heart J; 2000 Oct; 21(19):1572-3. PubMed ID: 10988008
[No Abstract] [Full Text] [Related]
27. Pravastatin versus simvastatin--what happens in the real world?
Levenstein S
S Afr Med J; 1995 May; 85(5):388-91. PubMed ID: 7638696
[No Abstract] [Full Text] [Related]
28. Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study.
Tonkin AM; Eckermann S; White H; Friedlander D; Glasziou P; Magnus P; Kirby A; Mulray S; Denton M; Sallaberger M; Hunt D; Simes J;
Am Heart J; 2006 Jun; 151(6):1305-12. PubMed ID: 16781242
[TBL] [Abstract][Full Text] [Related]
29. [Pharmacoeconomic evaluation of pravastatin in coronary secondary prevention in patients with myocardial infarct or unstable angina pectoris. An analysis based on the LIPID Study].
Szucs TD; Bertel O; Darioli R; Gutzwiller F; Mordasini R
Praxis (Bern 1994); 2000 Apr; 89(18):745-52. PubMed ID: 10823012
[TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up of the West of Scotland Coronary Prevention Study.
DeFilippis AP; Bansal S; Blumenthal RS
N Engl J Med; 2008 Jan; 358(2):194; author reply 194-5. PubMed ID: 18193527
[No Abstract] [Full Text] [Related]
31. Cost implications of lipid-lowering treatments.
Reckless JP
Pharmacoeconomics; 1994 Oct; 6(4):310-23. PubMed ID: 10147467
[TBL] [Abstract][Full Text] [Related]
32. Cholesterol-lowering drugs for primary prevention? The WOSCOP Study.
Muntoni S
Pharmacol Res; 1997 Mar; 35(3):169-70. PubMed ID: 9229402
[No Abstract] [Full Text] [Related]
33. Economic benefit analysis of primary prevention with pravastatin. Modelling economic benefits after such long term treatment is inappropriate.
Pharoah P
BMJ; 1998 Apr; 316(7139):1241-2. PubMed ID: 9553009
[No Abstract] [Full Text] [Related]
34. Hypercholesterolemia is common after pediatric heart transplantation: initial experience with pravastatin.
Seipelt IM; Crawford SE; Rodgers S; Backer C; Mavroudis C; Seipelt RG; Pahl E
J Heart Lung Transplant; 2004 Mar; 23(3):317-22. PubMed ID: 15019641
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up of the West of Scotland Coronary Prevention Study.
Ford I; Murray H; Packard CJ; Shepherd J; Macfarlane PW; Cobbe SM;
N Engl J Med; 2007 Oct; 357(15):1477-86. PubMed ID: 17928595
[TBL] [Abstract][Full Text] [Related]
36. [One year after WOSCOP, what is the correct pharmacological treatment of primary hypercholesterolemia? Réflexions du Groupe de Pharmacologie Clinique de la Société Française de Cardiologie].
Therapie; 1996; 51(6):611-4. PubMed ID: 9163995
[No Abstract] [Full Text] [Related]
37. Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies.
Elam MB; Cushman W; Applegate WB; Heimberg M
Tenn Med; 1997 May; 90(5):189-92. PubMed ID: 9130876
[No Abstract] [Full Text] [Related]
38. The effects of pravastatin on hospital admission in hypercholesterolemic middle-aged men: West of Scotland Coronary Prevention Study.
J Am Coll Cardiol; 1999 Mar; 33(4):909-15. PubMed ID: 10091815
[TBL] [Abstract][Full Text] [Related]
39. Cholesterol and coronary heart disease: new data from the WOSCOP Study.
Poli A
Pharmacol Res; 1997 Mar; 35(3):171-2. PubMed ID: 9229403
[No Abstract] [Full Text] [Related]
40. RE: M Thomas. The change of cost: reference-based pricing and the statins. 1999;15:535-8.
McNee W
Can J Cardiol; 1999 Nov; 15(11):1287. PubMed ID: 10841625
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
